MicroRNAs as potential cancer therapeutics
- PMID: 19956180
- PMCID: PMC10033140
- DOI: 10.1038/onc.2009.353
MicroRNAs as potential cancer therapeutics
Abstract
MicroRNAs (miRNAs) have been shown to have an important role in various cellular processes, such as apoptosis, differentiation and development. Recent studies have shown that miRNAs are mis-expressed in human cancers where they can exert their effect as oncogenes or tumor suppressors. Here, we review the potential for using miRNAs as biomarkers for diagnosis, prognosis and cancer therapies.
Conflict of interest statement
Conflict of interest
FJ Slack and JB Weidhaas own equity in 3primiR and have received grant support from Asuragen. They also hold a number of pending patents in the miRNA area. The remaining author declares no conflict of interest.
References
-
- Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297. - PubMed
-
- Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP et al. (2007). MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901–1908. - PubMed
-
- Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al. (2008). The miR-15a-miR-16–1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271–1277. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
